The BJUI's Clinical Trials Initiative
March 2017
in “
BJU international
”
TLDR The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.
The BJUI (British Journal of Urology International) is committed to supporting clinical trials, particularly Randomised Clinical Trials (RCTs), which are considered the highest level of evidence-based medicine. The journal acknowledges the challenges associated with RCTs, such as funding, patient accrual, execution, and reaching endpoints, but also recognizes their importance in providing unbiased treatment effect estimates and settling clinical debates. The BJUI aims to support clinical trials by publishing primary endpoint papers, important secondary endpoint papers, trial design papers, and early phase trials. It also engages readers through its website's Blogs section, which facilitates immediate dialogue on RCTs published elsewhere. The BJUI has introduced strategies to highlight RCT-related papers, invite expert commentary, and ensure rigorous RCT design and reporting standards, including adherence to the CONSORT guidelines and mandatory trial registration before patient enrollment. The article cites the impact of the Prostate Cancer Prevention Trial and the ProtecT study as examples of influential RCTs.
